Tokio Marine Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.65M Buy
62,063
+8,893
+17% +$483K 0.08% 199
2026
Q1
$3.34M Buy
53,170
+2,864
+6% +$229K 0.12% 144
2025
Q4
$4.8M Hold
50,306
0.17% 103
2025
Q3
$4.91M Buy
50,306
+788
+2% +$81.6K 0.17% 100
2025
Q2
$5.32M Buy
49,518
+2,355
+5% +$238K 0.2% 87
2025
Q1
$4.76M Buy
47,163
+2,930
+7% +$295K 0.17% 121
2024
Q4
$3.95M Buy
44,233
+2,348
+6% +$207K 0.14% 137
2024
Q3
$3.51M Buy
41,885
+998
+2% +$78.7K 0.15% 104
2024
Q2
$3.15M Buy
40,887
+3,763
+10% +$275K 0.15% 105
2024
Q1
$2.54M Buy
37,124
+304
+0.8% +$19.5K 0.13% 124
2023
Q4
$2.13M Buy
36,820
+4,889
+15% +$261K 0.12% 133
2023
Q3
$1.69M Buy
31,931
+3,033
+10% +$159K 0.11% 139
2023
Q2
$1.56M Buy
28,898
+2,496
+9% +$130K 0.1% 139
2023
Q1
$1.32M Buy
26,402
+2,375
+10% +$112K 0.09% 155
2022
Q4
$1.11M Buy
24,027
+2,634
+12% +$114K 0.09% 173
2022
Q3
$829K Buy
21,393
+2,179
+11% +$87.4K 0.07% 183
2022
Q2
$716K Buy
19,214
+3,135
+19% +$128K 0.06% 194
2022
Q1
$712K Buy
16,079
+2,549
+19% +$110K 0.06% 196
2021
Q4
$575K Buy
13,530
+699
+5% +$29.4K 0.05% 235
2021
Q3
$557K Buy
12,831
+1,930
+18% +$85.4K 0.05% 212
2021
Q2
$466K Buy
10,901
+845
+8% +$35.5K 0.04% 228
2021
Q1
$389K Buy
10,056
+88
+0.9% +$3.33K 0.04% 228
2020
Q4
$359K Buy
9,968
+1,655
+20% +$59.6K 0.04% 218
2020
Q3
$318K Buy
8,313
+1,234
+17% +$47.6K 0.04% 203
2020
Q2
$249K Buy
7,079
+539
+8% +$19.4K 0.04% 211
2020
Q1
$213K Buy
6,540
+1,309
+25% +$51.1K 0.04% 201
2019
Q4
$237K Buy
+5,231
New +$219K 0.04% 217
2018
Q1
Sell
-8,622
Closed -$214K 260
2017
Q4
$214K Sell
8,622
-3,287
-28% -$90.7K 0.03% 288
2017
Q3
$347K Sell
11,909
-3,865
-25% -$107K 0.05% 244
2017
Q2
$437K Sell
15,774
-5,817
-27% -$154K 0.06% 230
2017
Q1
$537K Sell
21,591
-6,097
-22% -$148K 0.07% 223
2016
Q4
$599K Sell
27,688
-10,124
-27% -$221K 0.07% 187
2016
Q3
$900K Sell
37,812
-4,643
-11% -$111K 0.1% 172
2016
Q2
$992K Buy
42,455
+1,509
+4% +$32.6K 0.1% 165
2016
Q1
$770K Buy
40,946
+76
+0.2% +$1.33K 0.08% 210
2015
Q4
$754K Sell
40,870
-4,610
-10% -$82.6K 0.08% 207
2015
Q3
$746K Sell
45,480
-2,911
-6% -$49.8K 0.08% 225
2015
Q2
$857K Sell
48,391
-7,805
-14% -$139K 0.08% 210
2015
Q1
$997K Sell
56,196
-6,788
-11% -$107K 0.09% 215
2014
Q4
$835K Sell
62,984
-23,763
-27% -$304K 0.07% 267
2014
Q3
$1.02M Sell
86,747
-11,710
-12% -$147K 0.07% 274
2014
Q2
$1.26M Sell
98,457
-2,775
-3% -$36.1K 0.09% 242
2014
Q1
$1.37M Sell
101,232
-8,335
-8% -$109K 0.09% 224
2013
Q4
$1.32M Sell
109,567
-7,512
-6% -$88.8K 0.08% 241
2013
Q3
$1.38M Sell
117,079
-1,955
-2% -$21.1K 0.09% 232
2013
Q2
$1.1M Buy
+119,034
New +$1.01M 0.07% 296

Other funds holding BSX

Tokio Marine Asset Management's BSX Position: Q2 2026 in Review

Tokio Marine Asset Management increased its Boston Scientific (BSX) stake by 17% in Q2 2026, buying an estimated $483K and bringing the position to 62,063 shares worth $2.65M. The position accounts for 0.08% of the portfolio, ranked #199.

Tokio Marine Asset Management first reported a position in BSX in Q2 2013 and has held it in 46 quarters since. The position peaked at $5.32M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Tokio Marine Asset Management held 62,063 shares of Boston Scientific worth $2.65M as of Q2 2026.
  • Tokio Marine Asset Management bought 8,893 Boston Scientific shares in Q2 2026, an estimated $483K.
  • Boston Scientific made up 0.08% of Tokio Marine Asset Management's portfolio in Q2 2026, its #199 holding.
  • Tokio Marine Asset Management first reported a position in Boston Scientific in Q2 2013 and has held it in 46 quarters since.
  • Tokio Marine Asset Management's Boston Scientific position peaked at $5.32M in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Tokio Marine Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.